Related Experiment Video
Updated: Mar 17, 2026
Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning
Published on: August 29, 2025
Validity and reliability of a quality-of-life assessment instrument in children aged between 6 and 11 years
Nilüfer Demirsoy1, Omur Sayligil
1Dr. Nilüfer Demirsoy, Department of History of Medicine and Ethics,, Faculty of Medicine, Eskisehir Osmangazi University,, Eskisehir 26480, Turkey, T: +902222290170, nilufer_p2@hotmail.com, ORCID: http://orcid.org/0000-0002-2647-0807.
Insights
The Turkish version of the Child Health and Illness Profile - Child Edition (CHIP-CE) is a reliable and valid tool for assessing the health of children aged 6-11.
Area of Science:
- Pediatric Health Assessment
- Cross-cultural Adaptation of Health Instruments
- Child Psychology and Development
Background:
- Growing importance of children's self-reported health.
- Challenges in systematic, community-based health assessments for children.
- Need for culturally validated health measurement tools.
Purpose of the Study:
- Evaluate the validity and reliability of the Turkish version of the Child Health and Illness Profile - Child Edition (CHIP-CE) for children aged 6-11.
- Adapt the CHIP-CE (6-11) for the Turkish population.
- Assess the instrument's suitability for both healthy children and those receiving medical treatment.
Main Methods:
- Cross-sectional analytical study conducted in Turkey.
- Cultural adaptation of the CHIP-CE (6-11) using translation and back-translation.
- Face-to-face interviews with 235 children (inpatients and healthy controls) aged 6-11.
- Confirmatory factor analysis (CFA) for construct validity.
- Cronbach's alpha and item-total correlations for reliability testing.
Main Results:
- The Turkish CHIP-CE (6-11) demonstrated excellent reliability with Cronbach's alpha values of 0.79 (inpatients) and 0.80 (healthy children).
- Confirmatory factor analysis results were consistent with established standards for both groups.
- The instrument was administered to a diverse sample of 235 children.
Conclusions:
- The culturally adapted Turkish version of the CHIP-CE (6-11) is a reliable and valid instrument for assessing child health.
- The internal consistency of the Turkish CHIP-CE is acceptable.
- The study provides a valuable tool for pediatric health research and clinical practice in Turkey.
Background:
There is increasing recognition of the importance of obtaining children's reports of their health, but significant challenges remain in accomplishing these goals in a systematic, community-based approach.
Objectives:
The aim of study was to evaluate the validity and reliability of the culturally adapted Turkish version of the "Child Health and Illness Profile - Child Edition (CHIP-CE) (6-11) for children 6 to 11 years of age.
Design:
Cross-sectional analytical study conducted at Eskisehir Osmangazi University, Faculty of Medicine, Department of Pediatrics, Eskisehir, Turkey.
Setting:
Children's health and diseases clinic.
Patients And Methods:
For the purpose of this study, face-to-face interviews were conducted with inpatients (children aged between 6 and 11 years staying in the hospital) and healthy children (children aged between 6 and 11 years attending a private elementary school in the spring semester of 2010-2011). The Turkish version of CHIP-CE (6-11) was administered after the original version of CHIP-CE in English was translated into Turkish, and then back translated into English. All steps in the cultural adaptation process were undertaken meticulously by an expert committee. Confirmatory factor analysis (CFA) was conducted to test construct validity. The Cronbach's alpha and item-total correlations were used to evaluate internal consistency for reliability testing.
Main Outcome Measures:
Domain scores on the CHIP-CE questionnaire, Cronbach's alpha and item-total correlations.
Results:
The Turkish version of CHIP-CE (6-11) was administered to 235 children, including 109 (46.4%) girls and 126 (53.6%) boys receiving inpatient treatment in the hospital, and 194 healthy children, including 89 (45.9%) girls and 105 (54.1%) boys. The mean (standard deviation) age was 6.9 (1.6) years in the group of children receiving inpatient treatment, and 9.2 (1.6) years in the healthy children. In the reliability testing of the CHIP-CE form, Cronbach's alpha was 0.79 in children receiving inpatient treatment, and 0.80 in healthy children. These values indicate excellent reliability. The CFA measurement model produced results consistent with standards: c2=185.76 df=160 P=.07986 RMSEA=0.026 in the children receiving inpatient treatment, and c2=180.20 df=109 P=.00002 RMSEA=0.058 in healthy children.
Conclusion:
CHIP-CE proved to be a reliable and valid measurement instrument for children receiving treatment for various diseases and healthy children. The internal consistency of the Turkish version of CHIP-CE is acceptable.
Limitations:
The sample, although large and diverse, was self-selected and does not represent the population of children in Turkey.
